Is Dr. Arman continuing to work at Nimble while acting as President of Cytodyn? He is still listed as CBO on their website. He has only been there since Sept of last year. This CC was nothing more than a "were working on it" update. Did not hear any earth-shattering news. Still can't overcome the clinical hold, still no NASH data, still no CEO. The inventory of LL they got from Samsung has got to be coagulating like honey by now. Still chasing the COVID indication - why? It's a waste of time and money at this point. I'm sure a lot of people thought this was upbeat and "promising". I guess people hear what they want to hear but at some point, this company needs to deliver something that generates revenue.
Market Data 
Markets 
AI
